These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 32170458)
21. Prognostic markers and standard management of chronic lymphocytic leukemia. Stilgenbauer S Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745 [TBL] [Abstract][Full Text] [Related]
22. Combination of Targeted Drugs to Control Chronic Lymphocytic Leukemia: Harnessing the Power of New Monoclonal Antibodies in Combination With Ibrutinib. Cramer P; Langerbeins P; Hallek M Cancer J; 2016; 22(1):62-6. PubMed ID: 26841018 [TBL] [Abstract][Full Text] [Related]
23. [Current diagnosis and treatment of chronic lymphocytic leukaemia]. Cramer P; von Tresckow J; Eichhorst B; Hallek M Dtsch Med Wochenschr; 2020 Aug; 145(16):1139-1144. PubMed ID: 32791549 [TBL] [Abstract][Full Text] [Related]
24. Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T. Wiedmeier-Nutor J; Leis J Curr Treat Options Oncol; 2022 Jun; 23(6):904-919. PubMed ID: 35435617 [TBL] [Abstract][Full Text] [Related]
26. Current Approaches and Novel Agents in the Treatment of Chronic Lymphocytic Leukemia. Cheson BD; Sharman JP JCO Oncol Pract; 2024 Oct; 20(10):1360-1366. PubMed ID: 38848511 [TBL] [Abstract][Full Text] [Related]
27. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia. Rossi D; Gerber B; Stüssi G Leuk Lymphoma; 2017 Jul; 58(7):1548-1560. PubMed ID: 27808579 [TBL] [Abstract][Full Text] [Related]
28. How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment Options. Yeung CCS; Shadman M Curr Oncol Rep; 2019 Jul; 21(8):74. PubMed ID: 31327069 [TBL] [Abstract][Full Text] [Related]
29. How and when I do allogeneic transplant in CLL. Gribben JG Blood; 2018 Jul; 132(1):31-39. PubMed ID: 29752258 [TBL] [Abstract][Full Text] [Related]
31. Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia. Wendtner CM; Gregor M Leuk Lymphoma; 2018 Feb; 59(2):300-310. PubMed ID: 28565930 [TBL] [Abstract][Full Text] [Related]
32. An evaluation of zanubrutinib, a BTK inhibitor, for the treatment of chronic lymphocytic leukemia. Geethakumari PR; Awan F Expert Rev Hematol; 2020 Oct; 13(10):1039-1046. PubMed ID: 32869675 [TBL] [Abstract][Full Text] [Related]
33. The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia. Vitale C; Ferrajoli A Expert Rev Hematol; 2020 Aug; 13(8):885-894. PubMed ID: 32700593 [TBL] [Abstract][Full Text] [Related]
34. [State of the art molecular diagnostics and therapy of chronic lymphocytic leukaemia in the era of new targeted therapies]. Gurbity Pálfi T; Fésüs V; Bödör C; Borbényi Z Orv Hetil; 2017 Oct; 158(41):1620-1629. PubMed ID: 29025288 [TBL] [Abstract][Full Text] [Related]
35. The evolving treatment landscape of chronic lymphocytic leukemia. Schiattone L; Ghia P; Scarfò L Curr Opin Oncol; 2019 Nov; 31(6):568-573. PubMed ID: 31593975 [TBL] [Abstract][Full Text] [Related]
36. Management of elderly and unfit patients with chronic lymphocytic leukemia. Mauro FR; Salaroli A; Caputo MD; Colafigli G; Petrucci L; Campanelli M; Ferretti A; Guarini AR; Foà R Expert Rev Hematol; 2016 Dec; 9(12):1165-1175. PubMed ID: 27796157 [TBL] [Abstract][Full Text] [Related]